AptarGroup (ATR) announced it has developed a dual-active material science technology engineered to simultaneously control moisture and oxygen. The company stated this technology is designed to provide a singular solution to address degradation drivers for pharmaceutical drugs, including oral solid dose GLP-1 medications, and medical devices. The new solution marks a breakthrough in the pharmaceutical industry and extends Aptar’s 3-Phase Activ-Polymer technology into new use cases.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.